Your browser doesn't support javascript.
loading
Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study.
Kim, Sung Han; Kim, Sohee; Nam, Byung-Ho; Lee, Sang Eun; Kim, Choung-Soo; Seo, Ill Young; Kim, Tae Nam; Hong, Sung-Hoo; Kwon, Tae Gyun; Seo, Seong Il; Joo, Kwan Joong; Song, Kanghyon; Kwak, Cheol; Chung, Jinsoo.
Afiliação
  • Kim SH; Departments of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Republic of Korea.
  • Kim S; Division of Cancer Epidemiology and Prevention, Research Institute and Hospital, National Cancer Center, Biometric Research Branch, Goyang, Republic of Korea.
  • Nam BH; Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
  • Lee SE; Department of Urology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim CS; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Seo IY; Department of Urology, Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Republic of Korea.
  • Kim TN; Department of Urology, Pusan National University Hospital, Busan, Republic of Korea.
  • Hong SH; Department of Urology, Seoul St. Mary's Hospital, The Catholic University, Seoul, Republic of Korea.
  • Kwon TG; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Joo KJ; Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Song K; Department of Urology, Korea Cancer Center Hospital, Seoul, Republic of Korea.
  • Kwak C; Department of Urology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Chung J; Departments of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Republic of Korea.
Biomed Res Int ; 2017: 9215930, 2017.
Article em En | MEDLINE | ID: mdl-28271073
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Compostos de Fenilureia / Carcinoma de Células Renais / Niacinamida / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Biomed Res Int Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Compostos de Fenilureia / Carcinoma de Células Renais / Niacinamida / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Biomed Res Int Ano de publicação: 2017 Tipo de documento: Article